$92.95
0.760.82%
At close: Dec 16, 4:00 PM EST
$92.85
-0.0981-0.11%
After Hours: 4:38 PM EST
Comments
Loading...
Boston Scientific Stock Guidance | NYSE:BSX | Benzinga
Boston Scientific issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10/22/2025 | BSX | Boston Scientific | Q4 | 2025 | $0.77 | $0.79 | $0.71 | $5.22B | $5.31B | $4.97B | Get Alert |
| 10/22/2025 | BSX | Boston Scientific | FY | 2025 | $3.02 | $3.04 | $2.98 | $20.10B | $20.10B | $19.87B | Get Alert |
| 07/23/2025 | BSX | Boston Scientific | FY | 2025 | $2.95 | $2.99 | $2.91 | $19.76B | $19.93B | $19.48B | Get Alert |
| 07/23/2025 | BSX | Boston Scientific | Q3 | 2025 | $0.70 | $0.72 | $0.71 | $4.92B | $5.01B | $4.87B | Get Alert |
| 05/28/2025 | BSX | Boston Scientific | FY | 2025 | $2.87 | $2.94 | $2.88 | $19.26B | $19.59B | $19.48B | Get Alert |
| 05/28/2025 | BSX | Boston Scientific | Q2 | 2025 | $0.71 | $0.73 | $0.71 | $4.84B | $4.92B | $4.89B | Get Alert |
| 04/23/2025 | BSX | Boston Scientific | Q2 | 2025 | $0.71 | $0.73 | $0.71 | $4.84B | $4.92B | $4.78B | Get Alert |
| 04/23/2025 | BSX | Boston Scientific | FY | 2025 | $2.87 | $2.94 | $2.86 | $19.26B | $19.59B | $19.13B | Get Alert |
| 02/05/2025 | BSX | Boston Scientific | Q1 | 2025 | $0.66 | $0.68 | $0.65 | $4.51B | $4.59B | $4.45B | Get Alert |
| 02/05/2025 | BSX | Boston Scientific | FY | 2025 | $2.80 | $2.87 | $2.81 | $18.84B | $19.18B | $18.79B | Get Alert |
| 10/23/2024 | BSX | Boston Scientific | Q4 | 2024 | $0.64 | $0.66 | $0.64 | $4.34B | $4.41B | $4.28B | Get Alert |
| 10/23/2024 | BSX | Boston Scientific | FY | 2024 | $2.45 | $2.47 | $2.41 | $16.59B | $16.59B | $16.29B | Get Alert |
| 07/24/2024 | BSX | Boston Scientific | Q3 | 2024 | $0.57 | $0.59 | $0.57 | $3.99B | $4.06B | $3.96B | Get Alert |
| 07/24/2024 | BSX | Boston Scientific | FY | 2024 | $2.38 | $2.42 | $2.33 | $16.16B | $16.30B | $16.00B | Get Alert |
| 04/24/2024 | BSX | Boston Scientific | FY | 2024 | $2.29 | $2.34 | $2.25 | $15.81B | $16.09B | $15.58B | Get Alert |
| 04/24/2024 | BSX | Boston Scientific | Q2 | 2024 | $0.57 | $0.59 | $0.56 | $3.98B | $4.05B | $3.93B | Get Alert |
| 01/31/2024 | BSX | Boston Scientific | FY | 2024 | $2.23 | $2.27 | $2.24 | $15.45B | $15.59B | $15.35B | Get Alert |
| 01/31/2024 | BSX | Boston Scientific | Q1 | 2024 | $0.50 | $0.52 | $0.52 | $3.64B | $3.71B | $3.67B | Get Alert |
| 10/26/2023 | BSX | Boston Scientific | FY | 2023 | $1.99 | $2.02 | $2.00 | $14.08B | $14.08B | $14.09B | Get Alert |
| 10/26/2023 | BSX | Boston Scientific | Q4 | 2023 | $0.49 | $0.52 | $0.52 | $3.53B | $3.60B | $3.63B | Get Alert |
| 09/20/2023 | BSX | Boston Scientific | FY | 2023 | $1.96 | $2.00 | $1.99 | $14.00B | $14.00B | $14.09B | Get Alert |
| 07/27/2023 | BSX | Boston Scientific | FY | 2023 | $1.96 | $2.00 | $1.95 | $14.01B | $14.14B | $13.95B | Get Alert |
| 07/27/2023 | BSX | Boston Scientific | Q3 | 2023 | $0.46 | $0.48 | $0.48 | $3.44B | $3.50B | $3.44B | Get Alert |
| 04/26/2023 | BSX | Boston Scientific | FY | 2023 | $1.90 | $1.96 | $1.91 | $13.76B | $14.01B | $13.55B | Get Alert |
| 04/26/2023 | BSX | Boston Scientific | Q2 | 2023 | $0.48 | $0.50 | $0.48 | $3.46B | $3.52B | $3.44B | Get Alert |
| 02/01/2023 | BSX | Boston Scientific | FY | 2023 | $1.86 | $1.93 | $1.93 | $13.32B | $13.57B | $13.46B | Get Alert |
| 02/01/2023 | BSX | Boston Scientific | Q1 | 2023 | $0.42 | $0.44 | $0.44 | $3.12B | $3.18B | $3.17B | Get Alert |
| 10/26/2022 | BSX | Boston Scientific | FY | 2022 | $1.71 | $1.74 | $1.76 | $12.66B | $12.66B | $12.71B | Get Alert |
| 10/26/2022 | BSX | Boston Scientific | Q4 | 2022 | $0.45 | $0.48 | $0.49 | $3.19B | $3.25B | $3.32B | Get Alert |
| 07/27/2022 | BSX | Boston Scientific | FY | 2022 | $1.74 | $1.77 | $1.76 | $12.66B | $12.78B | $12.82B | Get Alert |
| 07/27/2022 | BSX | Boston Scientific | Q3 | 2022 | $0.43 | $0.45 | $0.45 | $3.11B | $3.17B | $3.20B | Get Alert |
| 04/27/2022 | BSX | Boston Scientific | FY | 2022 | $1.74 | $1.79 | $1.77 | $12.72B | $12.96B | $12.84B | Get Alert |
| 04/27/2022 | BSX | Boston Scientific | Q2 | 2022 | $0.41 | $0.43 | $0.44 | $3.17B | $3.26B | $3.27B | Get Alert |
| 02/02/2022 | BSX | Boston Scientific | FY | 2022 | $1.73 | $1.79 | $1.87 | $12.60B | $12.84B | $12.93B | Get Alert |
| 02/02/2022 | BSX | Boston Scientific | Q1 | 2022 | $0.38 | $0.40 | $0.41 | $2.89B | $2.97B | $3.03B | Get Alert |
FAQ
Q
What is the most recent guidance for Boston Scientific (BSX)?
A
The most recent guidance for Boston Scientific (BSX) was reported on October 22, 2025 for Q4 2025. The company provided earnings per share guidance in the range of $0.77 to $0.79, compared to the estimated EPS of $0.71. Additionally, Boston Scientific forecasted revenue between $5.22B and $5.31B for the quarter.
Browse guidance and forecast on all stocks.
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved